BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37840995)

  • 1. Clinical Spectrum, Radiological Correlation and Outcome of Movement Disorders in Wilson's Disease.
    Mahale RR; Stezin A; Prasad S; Kamble N; Holla VV; Netravathi M; Yadav R; Pal PK
    Tremor Other Hyperkinet Mov (N Y); 2023; 13():37. PubMed ID: 37840995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Movement Disorder in Wilson Disease: Correlation with MRI and Biomarkers of Cell Injury.
    Kalita J; Kumar V; Misra UK; Kumar S
    J Mol Neurosci; 2021 Feb; 71(2):338-346. PubMed ID: 32662046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chapter 33: the history of movement disorders.
    Lanska DJ
    Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolution of Wing-Beating Tremor and Magnetic Resonance Imaging Lesions in Wilson's Disease Following Penicillamine.
    Brum IV; Parmera JB; Otani RTV; Prates IR; Lucato LT; Cury RG; Barbosa ER
    Tremor Other Hyperkinet Mov (N Y); 2024; 14():9. PubMed ID: 38464913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of patients with neurological form of Wilson's disease compliant to the de-coppering treatment.
    Stanković I; Jovanović Č; Vitković J; Svetel M; Pekmezović T; Tomić A; Kresojević N; Marković V; Ječmenica Lukić M; Petrović I; Dragašević-Mišković N; Kostić V
    J Neurol; 2023 Jul; 270(7):3492-3498. PubMed ID: 37016067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinsonism and other movement disorders in 23 cases of neurocysticercosis.
    Alarcón F; Cedeño Y; de Yébenes JG
    Parkinsonism Relat Disord; 2017 Sep; 42():47-53. PubMed ID: 28673613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric Manifestations of Wilson Disease: Correlation with MRI and Glutamate Excitotoxicity.
    Kalita J; Kumar V; Parashar V; Misra UK
    Mol Neurobiol; 2021 Nov; 58(11):6020-6031. PubMed ID: 34435331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The asymmetry of neural symptoms in Wilson's disease patients detecting by diffusion tensor imaging, resting-state functional MRI, and susceptibility-weighted imaging.
    Zhou XX; Li XH; Chen DB; Wu C; Feng L; Chu JP; Yang ZY; Li XB; Qin H; Li GD; Huang HW; Liang YY; Liang XL
    Brain Behav; 2018 May; 8(5):e00930. PubMed ID: 29761003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of neurological Wilson's disease without Kayser-Fleischer ring.
    Youn J; Kim JS; Kim HT; Lee JY; Lee PH; Ki CS; Cho JW
    J Neurol Sci; 2012 Dec; 323(1-2):183-6. PubMed ID: 23043908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation: treatment of choice for hepatic and neurological manifestation of Wilson's disease.
    Schumacher G; Platz KP; Mueller AR; Neuhaus R; Steinmüller T; Bechstein WO; Becker M; Luck W; Schuelke M; Neuhaus P
    Clin Transplant; 1997 Jun; 11(3):217-24. PubMed ID: 9193846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical Outcomes in Rare Movement Disorders: A Report of Seventeen Patients from India and Review of Literature.
    Dhar D; Holla VV; Kamble N; Yadav R; Srinivas D; Pal PK
    Tremor Other Hyperkinet Mov (N Y); 2022; 12():22. PubMed ID: 35811746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External Capsular Hyperintensities in Wilson's Disease Presenting with Refractory Status Epilepticus.
    Ruchika T; Madhukar M; Abhishek KG
    Neurol India; 2022; 70(6):2446-2448. PubMed ID: 36537433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical assessment of 31 patients with Wilson's disease. Correlations with structural changes on magnetic resonance imaging.
    Starosta-Rubinstein S; Young AB; Kluin K; Hill G; Aisen AM; Gabrielsen T; Brewer GJ
    Arch Neurol; 1987 Apr; 44(4):365-70. PubMed ID: 3827691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Wilson's disease motor complications with deep brain stimulation.
    Hedera P
    Ann N Y Acad Sci; 2014 May; 1315():16-23. PubMed ID: 24547944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory rTMS applied on somatosensory cortex in Wilson's disease patients with hand dystonia.
    Lozeron P; Poujois A; Meppiel E; Masmoudi S; Magnan TP; Vicaut E; Houdart E; Guichard JP; Trocello JM; Woimant F; Kubis N
    J Neural Transm (Vienna); 2017 Oct; 124(10):1161-1170. PubMed ID: 28689295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leucodystrophic CT changes in Wilson's disease.
    Basu S; Bhattacharya S; Das SK; Maity B
    J Assoc Physicians India; 1995 Jan; 43(1):66. PubMed ID: 9282648
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurological features and outcomes of Wilson's disease: a single-center experience.
    Samanci B; Sahin E; Bilgic B; Tufekcioglu Z; Gurvit H; Emre M; Demir K; Hanagasi HA
    Neurol Sci; 2021 Sep; 42(9):3829-3834. PubMed ID: 33474589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical profile of 103 patients with secondary movement disorders: correlation of etiology with phenomenology.
    Netravathi M; Pal PK; Indira Devi B
    Eur J Neurol; 2012 Feb; 19(2):226-33. PubMed ID: 21777351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wilson's disease: two treatment modalities. Correlations to pretreatment and posttreatment brain MRI.
    da Costa Mdo D; Spitz M; Bacheschi LA; Leite CC; Lucato LT; Barbosa ER
    Neuroradiology; 2009 Oct; 51(10):627-33. PubMed ID: 19479249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinsonism and tremor syndromes.
    Bellows S; Jankovic J
    J Neurol Sci; 2022 Feb; 433():120018. PubMed ID: 34686357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.